Pacer Advisors, Inc. Mersana Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.16 - $5.94 $3,706 - $10,193	1,716 New	1,716 $7,000
Q2 2021 Jul 21, 2021	SELL	$13.28 - $18.07 $57,475 - $78,206	-4,328 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$15.31 - $26.52 $1,347 - $2,333	88 Added 2.08%	4,328 $70,000
Q4 2020 Jan 20, 2021	BUY	$16.84 - $27.59 $49,711 - $81,445	2,952 Added 229.19%	4,240 $113,000
Q3 2020 Oct 19, 2020	BUY	$16.2 - $25.7 $20,865 - $33,101	1,288 New	1,288 $24,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.